BioInformatics | 96 pages | September 2003 | English
his First-Glance Market Report identifies the research objectives, methodologies, assay parameters and technological limitations that are currently associated with disease-based protein-profiling stud ...
The number of patients eligible for cardiovascular therapies is increasing quickly, and, as in the developed pharmaceutical markets, is primarily driven by increases in prevalence in diabetes and obes ...
IntroductionRecognizing that prolonging disease-free survival in chronic leukemia relies on the eradication of minimal residual disease has raised the bar for developers of novel pharmacotherapy. I ...
Datamonitor's Savient Pharmaceuticals Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the companys key business structu ...
IntroductionThis databook is a detailed information resource covering all the key data points on OTC Healthcare in Taiwan. It includes comprehensive value, segmentation and market share data. Th ...
Global Industry Analyst | 340 pages | October 2005 | English
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands of Units. The Product segments analyzed include HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Moni ...
The metrics in this report cover three year trends in Veterinary biological products [Manufacturing sector], broken out on a state-by-state basis. Analysis is based on data applied from 17 industry ...
The purpose of this report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by physicians to dia ...
Kalorama Information | 1 page | January 2008 | English
Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (Chinas pharmaceutical market, for ...
Partneringdesk deals and alliances in infectious diseases provides an in-depth view of over 1600 deals and alliances announced in infectious diseases between 2001 and 2006, in a clear and accessible P ...